Try our beta test site
3671 studies found for:    hormone therapy AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Completed Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women
Condition: Postmenopause
Interventions: Drug: Estradiol and Progesterone;   Drug: Estradiol and Drospirenone
22 Active, not recruiting Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors
Conditions: Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Intervention: Drug: Exemestane
23 Completed Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer
Condition: Breast Cancer
Intervention: Other: survey administration
24 Completed Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)
Conditions: Postmenopausal Vasomotor Symptoms;   Cardiovascular Disease
Interventions: Drug: 17-b-estradiol;   Drug: 17-b-estradiol + medroxyprogeterone acetate;   Drug: 17-b-estradiol hemihydrate;   Drug: placebo pill + gel
25 Completed Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
Conditions: Atherosclerosis;   Chlamydia Infections;   Cytomegalovirus Infections;   Pneumonia, Bacterial;   Postmenopause
Intervention: Drug: Estrogen therapy
26 Completed Compliance to a Hormone Therapy Regimen in Breast Cancer
Condition: Breast Cancer
Interventions: Behavioral: compliance monitoring;   Other: medical chart review;   Other: questionnaire administration
27 Completed The Women's Health Initiative Memory Study (The WHIMS Study)
Condition: Dementia Syndromes
Interventions: Drug: Estrogen hormone therapy;   Drug: Estrogen plus progesterone hormone therapy;   Drug: Placebo
28 Recruiting Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy
Conditions: Primary Non-metastatic Breast Cancer;   Who Remain Disease-free
Interventions: Drug: Everolimus;   Drug: Placebo
29 Active, not recruiting
Has Results
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Estrogen Receptor Positive;   Progesterone Receptor Positive;   Recurrent Breast Carcinoma;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Questionnaire Administration;   Drug: Tamoxifen Citrate
30 Recruiting A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy
Condition: Breast Cancer
Intervention: Behavioral: Individualized, tailored follow-up program
31 Terminated
Has Results
Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Conditions: Breast Cancer;   Cancer of the Breast;   Neoplasms, Breast
Interventions: Drug: Estrace;   Drug: Anastrozole
32 Completed Study of Paxil Use in Menopausal Women
Condition: Menopause
Interventions: Drug: Paroxetine;   Drug: placebo
33 Withdrawn Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy
Condition: Breast Cancer Female
Interventions: Behavioral: Behavioral Intervention.;   Other: Nutritional Education.
34 Active, not recruiting Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer
Condition: Breast Cancer Female
Interventions: Drug: letrozole, leuprorelin, fluorouracil, epirubicin, cyclophosphamide, docetaxel;   Drug: fluorouracil, epirubicin, cyclophosphamide, docetaxel
35 Completed Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: tamoxifen citrate;   Drug: toremifene
36 Recruiting Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
Condition: Female Breast Cancer
Intervention: Drug: Toremifene; Anastrozole
37 Completed Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Condition: Endometrial Cancer
Interventions: Drug: medroxyprogesterone;   Drug: ethinyl estradiol;   Drug: norgestrel;   Other: laboratory biomarker analysis
38 Recruiting Comparison of Efficacy and Tolerability of Fulvestrant+Placebo vs Fulvestrant+Palbociclib as First Line Therapy for Postmenopausal Women With HR+ Metastatic BC Treated With 5 Years of Hormonal Therapy Remaining Disease Free More Than 12 Months After Completion or Have de Novo Metastatic Disease
Condition: Breast Neoplasms
Interventions: Drug: PD-0332991 (Palbociclib);   Drug: Fulvestrant;   Drug: Placebo
39 Completed Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: fenretinide;   Drug: tamoxifen citrate
40 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Tamoxifen Citrate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.